- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/255 - Salmonella (G)
Détention brevets de la classe C07K 14/255
Brevets de cette classe: 199
Historique des publications depuis 10 ans
|
13
|
18
|
16
|
16
|
15
|
20
|
12
|
4
|
12
|
5
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Katholieke Universiteit Leuven | 1198 |
8 |
| Cleveland BioLabs, Inc. | 19 |
7 |
| The Cleveland Clinic Foundation | 1573 |
6 |
| The Regents of the University of California | 20015 |
5 |
| Industry Foundation of Chonnam National University | 653 |
5 |
| Prokarium Limited | 32 |
5 |
| University of Kansas | 877 |
5 |
| University of Maryland, Baltimore | 1023 |
5 |
| VaxInnate Corporation | 18 |
5 |
| Emory University | 1625 |
4 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3361 |
4 |
| University of Massachusetts | 2231 |
4 |
| Georgia Tech Research Corporation | 2754 |
3 |
| The Board of Regents for Oklahoma State University | 156 |
3 |
| Eth Zurich | 1283 |
3 |
| Institut Pasteur de Lille | 175 |
3 |
| Nomad Bioscience GmbH | 44 |
3 |
| Regents of the University of Minnesota | 2692 |
3 |
| Bavarian Nordic A/S | 259 |
3 |
| The General Hospital Corporation | 4751 |
2 |
| Autres propriétaires | 113 |